Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Agilent Acquires Its Analytic Joint Venture

By Biotechdaily staff writers
Posted on 16 Feb 2006
Agilent Technologies Inc. More...
(Palo Alto, CA, USA), and Yokogawa Electric Corp. (Tokyo, Japan) have announced that their joint venture, Yokogawa Analytical Systems, became a wholly owned Agilent subsidiary on February 1, 2006.

Yokogawa Analytical Systems was founded as a joint venture by Agilent and Yokogawa Electric in 1992. The company designed and produced measurement and control and industrial automation systems, including inductively coupled plasma mass spectrometry (ICP/MS) systems, which are analytic systems used in gas chromatography for laboratory and other scientific applications. Agilent and Yokogawa noted that the joint venture achieved its original objectives.

Agilent decided that it is the right time for Yokogawa Analytical Systems to become a wholly owned subsidiary in order to expand the market presence for its products and services in Japan. By selling its stake in the joint venture, Yokogawa Electric will be able to dedicate additional resources to its core businesses. The firm is receiving approximately U.S.$106 million for the transaction, including $98 million from Agilent for its 49% share in the joint venture, and $7.5 million in dividends from Yokogawa Analytical Systems.

Yokogawa Electric was founded in 1915 and is engaged in research and innovation. Its core businesses are industrial automation and control, test and measurement, information systems, and industry support.

"Yokogawa and Agilent have had a very strong, cooperative relationship over the past 13 years,” said Ryuji Kanno, president, Yokogawa Analytical Systems. "This acquisition of Yokogawa's minority share is a positive step for both companies.”



Related Links:
Agilent
Yokogawa

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.